Chicago Partners Investment Group LLC purchased a new position in shares of UiPath, Inc. (NYSE:PATH - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 469,188 shares of the company's stock, valued at approximately $6,630,000. Chicago Partners Investment Group LLC owned approximately 0.09% of UiPath as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently bought and sold shares of PATH. BlackRock Inc. raised its stake in shares of UiPath by 7.2% during the second quarter. BlackRock Inc. now owns 46,153,124 shares of the company's stock valued at $501,684,000 after purchasing an additional 3,097,822 shares during the period. Squarepoint Ops LLC boosted its stake in shares of UiPath by 8,065.7% in the second quarter. Squarepoint Ops LLC now owns 1,497,555 shares of the company's stock valued at $16,278,000 after purchasing an additional 1,516,355 shares during the period. Dimensional Fund Advisors LP grew its holdings in UiPath by 26.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 6,831,288 shares of the company's stock valued at $75,818,000 after purchasing an additional 1,437,843 shares in the last quarter. Bank of America Corp DE grew its holdings in UiPath by 13.2% during the 1st quarter. Bank of America Corp DE now owns 10,046,699 shares of the company's stock valued at $111,518,000 after purchasing an additional 1,170,285 shares in the last quarter. Finally, Corient Private Wealth LP increased its stake in UiPath by 398.4% during the 2nd quarter. Corient Private Wealth LP now owns 708,146 shares of the company's stock worth $7,698,000 after buying an additional 566,074 shares during the period. Hedge funds and other institutional investors own 62.50% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on PATH. KeyCorp reissued a "sector weight" rating on shares of UiPath in a research report on Thursday, September 24th. Oppenheimer restated a "market perform" rating on shares of UiPath in a research note on Friday, September 4th. BMO Capital Markets cut their price target on UiPath from $18.00 to $15.00 and set a "market perform" rating on the stock in a research note on Thursday, September 24th. Wells Fargo & Company increased their price target on UiPath from $13.00 to $15.00 and gave the company an "equal weight" rating in a report on Friday, September 4th. Finally, TD Cowen restated a "hold" rating and set a $16.00 price objective on shares of UiPath in a research note on Wednesday, September 23rd. Four investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, UiPath has an average rating of "Hold" and a consensus price target of $15.69.
Get Our Latest Analysis on UiPath
UiPath Price Performance
NYSE PATH opened at $12.99 on Friday. The company has a market capitalization of $6.77 billion, a price-to-earnings ratio of 19.38, a price-to-earnings-growth ratio of 1.27 and a beta of 1.04. UiPath, Inc. has a 12 month low of $9.20 and a 12 month high of $19.84. The company's fifty day moving average price is $14.04 and its two-hundred day moving average price is $12.40.
UiPath (NYSE:PATH - Get Free Report) last released its earnings results on Thursday, September 3rd. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. UiPath had a net margin of 21.03% and a return on equity of 9.70%. The company had revenue of $410.26 million during the quarter, compared to the consensus estimate of $397.77 million. During the same quarter in the previous year, the firm earned $0.15 EPS. The company's revenue was up 13.3% on a year-over-year basis. As a group, analysts anticipate that UiPath, Inc. will post 0.49 EPS for the current year.
Insider Transactions at UiPath
In other UiPath news, CEO Daniel Dines sold 1,250,000 shares of the company's stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $13.44, for a total transaction of $16,800,000.00. Following the sale, the chief executive officer owned 30,241,238 shares in the company, valued at $406,442,238.72. This represents a 3.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Raghavendra Malpani sold 29,565 shares of the stock in a transaction that occurred on Thursday, October 22nd. The stock was sold at an average price of $14.00, for a total value of $413,910.00. Following the transaction, the insider directly owned 1,484,716 shares in the company, valued at approximately $20,786,024. This represents a 1.95% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 2,962,735 shares of company stock valued at $43,584,098 in the last three months. Corporate insiders own 22.44% of the company's stock.
About UiPath
(
Free Report)
UiPath, Inc develops enterprise automation software that helps organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation with artificial intelligence, workflow orchestration, process mining, document processing and application integration capabilities.
The company's products are designed to support the discovery, development, deployment and management of software robots and AI-powered automations across functions such as finance, customer service, human resources, information technology and operations.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.